• / Free eNewsletters & Magazine
  • / My Account
Home>FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation

FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation

3party Content

Mon, 24 Nov 2014

FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.